- DKK85.02bn
- DKK99.15bn
- DKK39.73bn
- 45
- 49
- 70
- 55
2019 December 31st | 2020 December 31st | C2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 22,379 | 22,466 | 24,804 | 37,655 | 39,727 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 18,443 | 18,621 | 20,649 | 34,244 | 34,244 |
Operating Profit | 3,936 | 3,845 | 4,155 | 3,411 | 5,483 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,628 | 3,541 | 3,955 | 3,051 | 5,029 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,845 | 2,773 | 3,160 | 2,247 | 3,851 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2,843 | 2,773 | 3,157 | 2,247 | 3,851 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,843 | 2,773 | 3,158 | 2,247 | 3,851 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.47 | 7.45 | 6.12 | 4.62 | 6.92 |
Dividends per Share |